[18F]DCFPyL PET-MRI/CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: study protocol for a phase II trial

Rachel M Glicksman, Ur Metser, John Valliant, Peter W Chung, Neil E Fleshner, Robert G Bristow, David Green, Antonio Finelli, Robert Hamilton, Teodor Stanescu, Douglas Hussey, Charles Catton, Mary Gospodarowicz, Padraig Warde, Andrew Bayley, Stephen Breen, Doug Vines, David A Jaffray, Alejando Berlin

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of '[18F]DCFPyL PET-MRI/CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: study protocol for a phase II trial'. Together they form a unique fingerprint.

Medicine and Dentistry